Direct-to-consumer advertising of prescription drugs: Help or hindrance to the public's health?

Journal of Consumer Marketing

Volumn 22, Issue 7, 2005, Pages 429-431

  Finlayson, Greg ^a   Mullner, Ross ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Advertising; Health education; Pharmaceuticals industry; Prescription medicines; Public health

Indexed keywords

EID: 28844458000     PISSN: 07363761     EISSN: None     Source Type: Journal    
DOI: 10.1108/07363760510631174     Document Type: Article

References (5)

1. Berndt, J. (2005), "To inform or persuade? Direct-to-consumer advertising of prescription drugs", New England Journal of Medicine, Vol. 352 No. 4, pp. 325-8.
2. Holmer, A.F. (2002), "Direct-to-consumer advertising - strengthening our health care system", New England Journal of Medicine, Vol. 346 No. 7, pp. 526-8.
3. Lam, M.D. (2004), "A $20 billion bill and plenty of change", Pharmaceutical Executive, September.
4. Meek, C. (2001), Direct-to-Consumer Advertising of Prescription Medicine: A Review of International Policy and Evidence, Royal Pharmaceutical Society of Great Britain, London, available at: www.rpsgb.org.uk/ pdfs/dtcarep.pdf.
5. National Institute for Health Care Management Research and Education Foundation (2001), Prescription Drugs and Mass Media Advertising, 2000, NIHCM Foundation, Washington DC, November, available at: www.nihcm.org/ DTCbrief2001.pdf.